OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Bone marrow stromal cells-derived microRNA-181-containing extracellular vesicles inhibit ovarian cancer cell chemoresistance by downregulating MEST via the Wnt/β-catenin signaling pathway
Zhengyi Ruan, Lili Lu, Li Zhang, et al.
Cancer Gene Therapy (2020) Vol. 28, Iss. 7-8, pp. 785-798
Closed Access | Times Cited: 16
Zhengyi Ruan, Lili Lu, Li Zhang, et al.
Cancer Gene Therapy (2020) Vol. 28, Iss. 7-8, pp. 785-798
Closed Access | Times Cited: 16
Showing 16 citing articles:
Targeting Wnt Signaling in Cancer Drug Resistance: Insights from Pre-Clinical and Clinical Research
Kiavash Hushmandi, Mina Alimohammadi, Mohammad Heiat, et al.
Pathology - Research and Practice (2025) Vol. 267, pp. 155837-155837
Closed Access | Times Cited: 1
Kiavash Hushmandi, Mina Alimohammadi, Mohammad Heiat, et al.
Pathology - Research and Practice (2025) Vol. 267, pp. 155837-155837
Closed Access | Times Cited: 1
Epigenetic Regulation of the Wnt/β-Catenin Signaling Pathway in Cancer
Ankita Sharma, Rafeeq Mir, Sanjeev Galande
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 52
Ankita Sharma, Rafeeq Mir, Sanjeev Galande
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 52
RPN2 is targeted by miR-181c and mediates glioma progression and temozolomide sensitivity via the wnt/β-catenin signaling pathway
Jikui Sun, Quanfeng Ma, Banban Li, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 10
Open Access | Times Cited: 33
Jikui Sun, Quanfeng Ma, Banban Li, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 10
Open Access | Times Cited: 33
MicroRNA Nano-Shuttles: Engineering Extracellular Vesicles as a Cutting-Edge Biotechnology Platform for Clinical Use in Therapeutics
N. G. Menjivar, Jaiden Oropallo, Samuel Gebremedhn, et al.
Biological Procedures Online (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 4
N. G. Menjivar, Jaiden Oropallo, Samuel Gebremedhn, et al.
Biological Procedures Online (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 4
Emerging roles of exosomes in diagnosis, prognosis, and therapeutic potential in ovarian cancer: a comprehensive review
Thunwipa Tuscharoenporn, Nattayaporn Apaijai, Kittipat Charoenkwan, et al.
Cancer Gene Therapy (2025)
Closed Access
Thunwipa Tuscharoenporn, Nattayaporn Apaijai, Kittipat Charoenkwan, et al.
Cancer Gene Therapy (2025)
Closed Access
Long non-coding RNA NEAT1 facilitates the growth, migration, and invasion of ovarian cancer cells via the let-7 g/MEST/ATGL axis
Lili Yin, Yu Wang
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 22
Lili Yin, Yu Wang
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 22
miR-106a-5p carried by tumor-derived extracellular vesicles promotes the invasion and metastasis of ovarian cancer by targeting KLF6
Yunyun Zheng, Kang Zhu, Guihu Wang
Clinical & Experimental Metastasis (2022) Vol. 39, Iss. 4, pp. 603-621
Closed Access | Times Cited: 16
Yunyun Zheng, Kang Zhu, Guihu Wang
Clinical & Experimental Metastasis (2022) Vol. 39, Iss. 4, pp. 603-621
Closed Access | Times Cited: 16
Exosomes in ovarian cancer: impact on drug resistance and advances in SERS detection techniques
Biqing Chen, Xiaohong Qiu, Yang Li
Journal of Pharmaceutical Analysis (2024), pp. 101170-101170
Open Access | Times Cited: 3
Biqing Chen, Xiaohong Qiu, Yang Li
Journal of Pharmaceutical Analysis (2024), pp. 101170-101170
Open Access | Times Cited: 3
Mesenchymal Stem Cells in Adipose Tissue and Extracellular Vesicles in Ovarian Cancer Patients: A Bridge toward Metastatic Diffusion or a New Therapeutic Opportunity?
Gabriele Storti, Maria Giovanna Scioli, Bong‐Sung Kim, et al.
Cells (2021) Vol. 10, Iss. 8, pp. 2117-2117
Open Access | Times Cited: 20
Gabriele Storti, Maria Giovanna Scioli, Bong‐Sung Kim, et al.
Cells (2021) Vol. 10, Iss. 8, pp. 2117-2117
Open Access | Times Cited: 20
Cancer-associated adipocytes in the ovarian cancer microenvironment
Qiuling Cai, H. J. Yang, Huiling Shen, et al.
American Journal of Cancer Research (2024) Vol. 14, Iss. 7, pp. 3259-3279
Open Access | Times Cited: 2
Qiuling Cai, H. J. Yang, Huiling Shen, et al.
American Journal of Cancer Research (2024) Vol. 14, Iss. 7, pp. 3259-3279
Open Access | Times Cited: 2
Increased co-expression of MEST and BRCA1 is associated with worse prognosis and immune infiltration in ovarian cancer
Jing Zhang, Sihui Yu, Qingxian Li, et al.
Gynecologic Oncology (2022) Vol. 164, Iss. 3, pp. 566-576
Closed Access | Times Cited: 9
Jing Zhang, Sihui Yu, Qingxian Li, et al.
Gynecologic Oncology (2022) Vol. 164, Iss. 3, pp. 566-576
Closed Access | Times Cited: 9
Comprehensive Analysis of the Expression of Key Genes Related to Hippo Signaling and Their Prognosis Impact in Ovarian Cancer
Paul Kubelac, Cornelia Braicu, Lajos Ráduly, et al.
Diagnostics (2021) Vol. 11, Iss. 2, pp. 344-344
Open Access | Times Cited: 6
Paul Kubelac, Cornelia Braicu, Lajos Ráduly, et al.
Diagnostics (2021) Vol. 11, Iss. 2, pp. 344-344
Open Access | Times Cited: 6
Investigating function of long noncoding RNA of HOTAIRM1 in progression of SKOV3 ovarian cancer cells
Licui Ye, Meng Xia, Rui Xiang, et al.
Drug Development Research (2021) Vol. 82, Iss. 8, pp. 1162-1168
Closed Access | Times Cited: 5
Licui Ye, Meng Xia, Rui Xiang, et al.
Drug Development Research (2021) Vol. 82, Iss. 8, pp. 1162-1168
Closed Access | Times Cited: 5
Extracellular vesicles in cancer drug resistance: Mechanistic insights and therapeutic implications
Jing Zuo, Yan Han, Siyuan Qin, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 4
Open Access
Jing Zuo, Yan Han, Siyuan Qin, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 4
Open Access
MicroRNA‐33b replacement effect on growth and migration inhibition in ovarian cancer cells
Jin Liu, Weiming Wang, Limin Chen, et al.
Chemical Biology & Drug Design (2021) Vol. 101, Iss. 5, pp. 1019-1026
Closed Access | Times Cited: 3
Jin Liu, Weiming Wang, Limin Chen, et al.
Chemical Biology & Drug Design (2021) Vol. 101, Iss. 5, pp. 1019-1026
Closed Access | Times Cited: 3
MicroRNA‑181b‑5p insufficiency predicts treatment response failure risk and unfavorable event‑free survival as well as overall survival in acute myeloid leukemia patients
Huina Lu, Yi Ding, Yan Dong, et al.
Oncology Letters (2022) Vol. 24, Iss. 4
Open Access | Times Cited: 1
Huina Lu, Yi Ding, Yan Dong, et al.
Oncology Letters (2022) Vol. 24, Iss. 4
Open Access | Times Cited: 1
